# Impact of an Optimized Communication on the Readmission for Adverse Drug Event

> **NCT03725046** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 346 (actual)

## Conditions studied

- Adverse Drug Event

## Interventions

- **OTHER:** Optimized information transmission

## Key facts

- **NCT ID:** NCT03725046
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-19
- **Primary completion:** 2021-07-19
- **Final completion:** 2021-07-19
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03725046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03725046, "Impact of an Optimized Communication on the Readmission for Adverse Drug Event". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03725046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*